These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7992375)

  • 1. Transplantation in humans of encapsulated xenogeneic cells without immunosuppression. A preliminary report.
    Aebischer P; Buchser E; Joseph JM; Favre J; de Tribolet N; Lysaght M; Rudnick S; Goddard M
    Transplantation; 1994 Dec; 58(11):1275-7. PubMed ID: 7992375
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of immunosuppression on the development of xenogeneic trophoblast under the kidney capsule.
    Dehem A; Sobis H; Vandeputte M
    Transplantation; 1971 Jun; 11(6):578-80. PubMed ID: 5579355
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term host unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression.
    Peduto G; Rinsch C; Schneider BL; Rolland E; Aebischer P
    Transplantation; 2000 Jul; 70(1):78-85. PubMed ID: 10919579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of xenotransplant immunogenicity and immunosuppression on host MHC expression in the rat CNS.
    Czech KA; Ryan JW; Sagen J; Pappas GD
    Exp Neurol; 1997 Sep; 147(1):66-83. PubMed ID: 9294404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical perspectives of xenografts: encapsulated chromaffin cells and pain].
    Bès JC; Lazorthes Y; Sol JC; Tkaczuk J; Sallerin B
    Pathol Biol (Paris); 2000 May; 48(4):365-7. PubMed ID: 10868399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of xenografts by a combination of immunoisolation and a single dose of anti-CD4 antibody.
    Mckenzie AW; Georgiou HM; Zhan Y; Brady JL; Lew AM
    Cell Transplant; 2001; 10(2):183-93. PubMed ID: 11332633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral xenogeneic immunological response to encapsulated bovine adrenal chromaffin cells implanted within the sheep lumbar intrathecal space.
    Kaplan FA; Krueger PM; Harvey J; Goddard MB
    Transplantation; 1996 Apr; 61(8):1215-21. PubMed ID: 8610421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal xenogeneic chromaffin cell grafts reduce nociceptive behavior in a rodent tonic pain model.
    Sol JC; Sallerin B; Larrue S; Li RY; Jozan S; Tortosa F; Mascott C; Carraoue F; Tafani M; Lazorthes Y
    Exp Neurol; 2004 Apr; 186(2):198-211. PubMed ID: 15026256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrasplenic transplantation of encapsulated cells: a novel approach to cell therapy.
    Aoki T; Umehara Y; Ferraresso C; Sugiyama N; Middleton Y; Avital I; Inderbitzin D; Demetriou AA; Rozga J
    Cell Transplant; 2002; 11(6):553-61. PubMed ID: 12428745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status of xenotransplantation.
    Rebellato LM; Verbanac KM; Haisch CE
    Curr Surg; 2005; 62(5):481-8. PubMed ID: 16125603
    [No Abstract]   [Full Text] [Related]  

  • 12. Different immune effects on cardiac allografts and xenografts induced by neonatal intrathymic inoculation with allogeneic and xenogeneic antigens.
    Shen Z; Pelletier S; Mohiuddin M; Yokoyama H; Reiss GR; DiSesa VJ
    J Heart Lung Transplant; 1996 Oct; 15(10):1034-8. PubMed ID: 8913921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
    Sykes M
    Clin Transplant; 1996 Aug; 10(4):357-63. PubMed ID: 8884109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of transient immunosuppression using cyclosporine for xenomyoblast transplantation for cardiac repair.
    Haider HKh; Jiang SJ; Ye L; Aziz S; Law PK; Sim EK
    Transplant Proc; 2004; 36(1):232-5. PubMed ID: 15013354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulated cell technology.
    Lanza RP; Hayes JL; Chick WL
    Nat Biotechnol; 1996 Sep; 14(9):1107-11. PubMed ID: 9631060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells.
    Zurn AD; Henry H; Schluep M; Aubert V; Winkel L; Eilers B; Bachmann C; Aebischer P
    Cell Transplant; 2000; 9(4):471-84. PubMed ID: 11038064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy in transplantation.
    Giannoukakis N; Thomson A; Robbins P
    Gene Ther; 1999 Sep; 6(9):1499-511. PubMed ID: 10490759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed chimerism as an approach to transplantation tolerance.
    Sachs DH
    Clin Immunol; 2000 Apr; 95(1 Pt 2):S63-8. PubMed ID: 10729238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects of using organs and cells from pigs for transplantation into humans.
    Groth CG
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):20-5. PubMed ID: 17344582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of humoral immunization against encapsulated xenogeneic hepatocytes and prolongation of their function by 2-week cyclosporine treatment in the rat.
    Wen L; Grudé P; Conti F; Honiger J; Capeau J; Nordlinger B; Weill B; Calmus Y
    Surgery; 2000 Mar; 127(3):301-8. PubMed ID: 10715986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.